135 related articles for article (PubMed ID: 29759435)
21. Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.
Lampert R; Wang Y; Curtis JP
Am Heart J; 2013 Jun; 165(6):1015-1023.e2. PubMed ID: 23708175
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
Konstantino Y; Haim M; Boxer J; Goldenberg I; Feldman A; Michowitz Y; Glikson M; Suleiman M;
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):718-23. PubMed ID: 26852908
[TBL] [Abstract][Full Text] [Related]
23. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
[TBL] [Abstract][Full Text] [Related]
24. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2015].
Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Botto GL; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
G Ital Cardiol (Rome); 2017 Jan; 18(1):67-79. PubMed ID: 28287212
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
[TBL] [Abstract][Full Text] [Related]
26. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.
Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R
J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336
[TBL] [Abstract][Full Text] [Related]
27. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.
Matlock DD; Peterson PN; Wang Y; Curtis JP; Reynolds MR; Varosy PD; Masoudi FA
Arch Intern Med; 2012 Apr; 172(8):634-41; discussion 641. PubMed ID: 22529229
[TBL] [Abstract][Full Text] [Related]
28. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
29. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
30. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
[TBL] [Abstract][Full Text] [Related]
31. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
32. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2016].
Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
G Ital Cardiol (Rome); 2018 Feb; 19(2):119-131. PubMed ID: 29531385
[TBL] [Abstract][Full Text] [Related]
33. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing - annual report 2013].
Proclemer A; Zecchin M; D'Onofrio A; Botto GL; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
G Ital Cardiol (Rome); 2014 Nov; 15(11):638-50. PubMed ID: 25424143
[TBL] [Abstract][Full Text] [Related]
34. Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry.
Zeitler EP; Wang Y; Dharmarajan K; Anstrom KJ; Peterson ED; Daubert JP; Curtis JP; Al-Khatib SM
Circ Arrhythm Electrophysiol; 2016 Jul; 9(7):. PubMed ID: 27406605
[TBL] [Abstract][Full Text] [Related]
35. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
36. Should Single-Coil Implantable Cardioverter Defibrillator Leads Be Used in all Patients?
Almehmadi F; Manlucu J
Card Electrophysiol Clin; 2018 Mar; 10(1):59-66. PubMed ID: 29428142
[TBL] [Abstract][Full Text] [Related]
37. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.
Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M
Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580
[TBL] [Abstract][Full Text] [Related]
38. In-hospital complications associated with reoperations of implantable cardioverter defibrillators.
Steckman DA; Varosy PD; Parzynski CS; Masoudi FA; Curtis JP; Sauer WH; Nguyen DT
Am J Cardiol; 2014 Aug; 114(3):419-26. PubMed ID: 24927972
[TBL] [Abstract][Full Text] [Related]
39. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
[TBL] [Abstract][Full Text] [Related]
40. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R
Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
